Zevra Therapeutics, Inc.
USD13.52
+0.29 (+2.19%)
CEO
Neil F. McFarlane
IPO Date
2015-04-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$13.20
Prev. Close
$13.23
Day Low
$13.20
Day High
$13.82
52W Low
$7.16
52W High
$14.27
Market Cap
$0.80B
Volume
2.88M
| 34,557 |
| $12.68 |
| 23 Jun 2026 | Thompson Rahsaan | Chief Legal & Compliance | M-Exempt | Disposed | 66,667 | $0.00 |
| 18 Jun 2026 | FAVORITO TAMARA A | director | A-Award | Acquired | 30,000 | $11.17 |
| 18 Jun 2026 | Secor Alicia | director | A-Award | Acquired | 30,000 | $11.17 |
| 18 Jun 2026 | Watton Corey Michael | director | A-Award | Acquired | 30,000 | $11.17 |
| 18 Jun 2026 | Calder Douglas W | director | A-Award | Acquired | 30,000 | $11.17 |
| 18 Jun 2026 | Anderson Thomas | director | A-Award | Acquired | 30,000 | $11.17 |
| 18 Jun 2026 | Shih Alvin | director | A-Award | Acquired | 30,000 | $11.17 |
| 29 May 2026 | Sangiovanni Timothy J. | SVP, Finance & Corp Controller | A-Award | Acquired | 40,000 | $11.40 |